Received Dec 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Z011972 | — |
No adverse event; Product was administered to 3 patients; VAQTA that experienced a late shipment was told by shipper Sanofi product was not viable and marked "do not use".; This spontaneous report was received from an Administrator and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 04-DEC-2025, the patient was vaccinated with Hepatitis A Vaccine, Inactivated (VAQTA), (dose, administration route were not provided) (lot #Z011972 was determined to be valid, expiration date: 13-OCT-2026) administrated as prophylaxis. On an unknown date in 2025, the Hepatitis A Vaccine, Inactivated (VAQTA) experienced a late shipment (Product distribution issue). Due to this late shipment, on 04-DEC-2025, Hepatitis A Vaccine, Inactivated (VAQTA) was administered on unknown storage and temperature conditions (Poor quality product administered). No additional adverse events were reported. At the reporting time, the outcome of the events was unknown.